UCL Technology Fund

Investment Director David Grimm leads the investment team, operating under a partnership agreement with AlbionVC, which provides fund management services. UCL Business — the university's technology transfer arm — sources the majority of deals through its commercialization pipeline. The joint governance structure means investment decisions reflect both the university's scientific priorities and the venture discipline AlbionVC brings from its broader fund platform.

The fund draws exclusively from UCL's research base — 11 faculties spanning neuroscience, engineering, computer science, and medicine. UCL Business identifies and supports startup formation from disclosed inventions, filing the patents and negotiating licensing terms before the fund invests. This gives the vehicle first look at roughly 200 disclosures annually from a university that has produced more spinouts than any other UK institution.

It operates as a hybrid. UCL's endowment provides the capital base, UCL Business brings the deal flow, and AlbionVC manages the fund under a delegated investment management agreement. This tripartite arrangement gives the fund permanence — there is no external fundraising cycle — while maintaining the professional investment discipline of a regulated UK venture firm.

AlbionVC serves as the delegated fund manager, responsible for investment execution, portfolio monitoring and reporting under a formal agreement with UCL. The arrangement lets UCL leverage Albion's institutional venture platform — including its sector specialists, legal infrastructure and limited-partner networks — without building a stand-alone management company. AlbionVC has managed the UCL Technology Fund since its inception.

Yes. The fund writes initial pre-seed and seed checks up to £2 million and reserves capital for follow-on participation through Series A and later stages. The fund frequently co-invests alongside AlbionVC's other funds, as well as IP Group, Parkwalk Advisors and Cambridge Innovation Capital, forming a consortium model that supports university spinouts across the UK's Golden Triangle.

The fund invests only in commercializing UCL intellectual property, which constrains activity to fields where UCL holds world-class research departments. It does not pursue opportunities in consumer internet, fintech, or real estate unless there is a material technical advantage traceable to UCL research. Its mandate excludes pure service businesses and asset-light models with no scientific barrier to entry.

Returns flow back to UCL's endowment and, through it, into the university's research budget. The fund's structure does not distribute carried interest to a wide partner group — the primary beneficiary of realized gains is the academic institution itself. This reinvestment mechanism aligns fund performance with UCL's long-term research capacity rather than generating near-term liquidity for external LPs.